Fibrocell Science Inc.
FCSC
FCSC was delisted on the 12th of December, 2019.
0 hedge funds and large institutions have $0 invested in Fibrocell Science Inc. in 2019 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 22 closing their positions.
36.68% less ownership
Funds ownership: 36.68% → 0% (-37%)
100% less funds holding
Funds holding: 22 → 0 (-22)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
100% less capital inflows, than outflows
Capital inflows: $0 | Capital outflows: $10.6M
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 22
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TS
Third Security
Radford,
Virginia
|
-$4.89M |
| 2 |
Renaissance Technologies
New York
|
-$2.26M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$1.17M |
| 4 |
BCM
Beryl Capital Management
Redondo Beach,
California
|
-$883K |
| 5 |
MP
MSD Partners
New York
|
-$410K |
FCSC Hedge Fund Activity: Q4 2019 in Review
0 of the 5,094 institutional investors tracked by Wall St. Rank reported a position in Fibrocell Science Inc. (FCSC) for Q4 2019, worth a combined $0 — down 100% from $10.6M a quarter earlier.
Sellers outnumbered buyers: 22 funds closed out of FCSC and 0 opened new positions — a net loss of 22 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Third Security, exiting entirely with an estimated $4.89M sold.
- 0 institutional investors held Fibrocell Science Inc. (FCSC) as of Q4 2019, down from 22 in Q3 2019.
- Funds reported $0 of Fibrocell Science Inc. stock for Q4 2019, down 100% quarter-over-quarter.
- 0 funds opened new Fibrocell Science Inc. positions in Q4 2019 and 22 closed out, a net change of -22 holders.
- The largest Fibrocell Science Inc. seller in Q4 2019 was Third Security, an estimated $4.89M sold.
Based on aggregated 13F filings for Q4 2019.